Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Melanoma treatment details. Biologic therapy. Haukeland University Hospital, Bergen, Norway



Survival: 9.0 months
   
Toxicity Grade: 4
   
Treatments: Biologic therapy
   
Drugs:
Country: Norway
   
City/State/Province: Bergen
   
Hospital: Haukeland University Hospital
   
Journal: Link
   
Date: 6/2012

Description:
Patients:
This phase 2 study involved 35 metastatic melanoma patients with a median age of 63 years; 54% were male.

Treatment:
Patients were treated with the biologic therapy agent bevacizumab.

Toxicities:
The most severe toxicities were of grade 4 and included allergic reaction and pulmonary embolism. Grade 3 gastrointestinal disorders, heart problems, and increased blood pressure were also reported.

Results:
The median overall survival was 9 months. The median progression-free survival was 2.14 months.

Correspondence: Dr. Oddbjørn Straume; email: oddbjorn.straume@helse-bergen.no

E-mail to a Friend Email Physician More Information